ProCE Banner Activity

CE / CME

Holistic Approaches to Agitation Associated With Dementia due to Alzheimer’s Disease: ​A Long-term Care Perspective

Video

Long-term care perspectives of assessment and treatment approaches for agitation in Alzheimer’s dementia, including traditional and the FDA-approved therapies, while emphasizing the importance of identifying underlying triggers and tailoring interventions to individual patients.

Physician Assistants/Physician Associates: 0.75 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.75 Nursing contact hour

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Released: March 27, 2025

Expiration: March 26, 2026

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the Post-Acute and Long-Term Care Medical Association (PALTmed) 

ProCE Banner

Supporters

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Otsuka America Pharmaceutical, Inc. and Lundbeck

Partners

Society for Post Acute and Long-Term Care Medicine (PALTmed)

ProCE Banner

Target Audience

This activity is intended for healthcare professionals who care for patients with AAD in the long-term care setting, including geriatric psychiatrists, long-term care physicians, nurse practitioners, physician associates, and pharmacists.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Alzheimer's.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Describe the burden of untreated AAD in the long-term care setting

  • Employ evidence-based tools for the identification of AAD symptoms

  • Analyze the limitations of historical treatment options for AAD, including efficacy and safety of atypical antipsychotics

  • Evaluate the latest clinical evidence for new and emerging options for the treatment of AAD

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

George T. Grossberg, MD: consultant/advisor/speaker: Acadia, Axsome, Biogen, BioXcel, Bristol Myers Squibb, Eisai, Karuna, Lamplight, Lilly, Lundbeck, Otsuka, Takeda.

Sanjay Gupta, MD: consultant/advisor/speaker: AbbVie, Alkermes, Bristol Myers Squibb, Intracellular, Janssen, Neurocrine, Otsuka, Teva, Vanda.

The planners and content peer reviewers from Clinical Care Options, LLC and the Post-Acute and Long-Term Care Medical Association (PALTmed) do not have any relevant financial relationships to disclose, except Michael Asbach, DMSc, PA-C, as noted below.​

Michael Asbach, DMSc, PA-C: consultant/advisor/speaker: AbbVie, Axsome Therapeutics, Bristol Myers Squibb, Johnson & Johnson, Intra-Cellular, Neurocrine Biosciences, Otsuka, Sage/Biogen, Teva.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 27, 2025, through March 26, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-25-147-H01-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

AAPA CME Accreditation - AAPA

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until March 26, 2026. PAs should only claim credit commensurate with the extent of their participation.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.